PO9-212 EFFECT OF ROSIGLITAZONE ON LEUKOCYTE EXPRESSION OF PROINFLAMMATORY AND PROTHROMBOTIC MOLECULES IN PATIENTS WITH TYPE 2 DIABETES

Autor:	R. Dolezalova, Marinov I, Z. Kasalova, Richard Ceska, Tomáš Štulc, H. Krejci, Helena Svitavská Svobodová
Rok vydání:	2007
Předmět:	medicine.medical_specialty business.industry General Medicine Type 2 diabetes medicine.disease Proinflammatory cytokine Endocrinology Internal medicine Internal Medicine medicine In patient Cardiology and Cardiovascular Medicine Rosiglitazone business medicine.drug
Zdroj:	Atherosclerosis Supplements. 8:69
ISSN:	1567-5688
DOI:	10.1016/s1567-5688(07)71222-9
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::bcfe3c19edaca5c4c22341e1561a9d74 https://doi.org/10.1016/s1567-5688(07)71222-9 Zobrazit plný text záznamu Full Text from ScienceDirect